Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties.

Priyanka Sati, Eshita Sharma, Praveen Dhyani, Dharam Chand Attri, Rohit Rana, Lashyn Kiyekbayeva, Dietrich Büsselberg, Samson Mathews Samuel, Javad Sharifi-Rad
Author Information
  1. Priyanka Sati: Department of Biotechnology, Kumaun University, Bhimtal, Uttarakhand, India.
  2. Eshita Sharma: Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, Punjab, India.
  3. Praveen Dhyani: Institute for Integrated Natural Sciences, University of Koblenz, Koblenz, Germany.
  4. Dharam Chand Attri: Department of Botany, Central University of Jammu, Rahya-Suchani (Bagla), Jammu and Kashmir, India.
  5. Rohit Rana: Department of Biology, Brandeis University, Waltham, MA, USA.
  6. Lashyn Kiyekbayeva: Department of Pharmaceutical Technology, Pharmaceutical School, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  7. Dietrich Büsselberg: Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, P.O. Box 24144, Doha, Qatar. dib2015@qatar-med.cornell.edu.
  8. Samson Mathews Samuel: Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, P.O. Box 24144, Doha, Qatar. sms2016@qatar-med.cornell.edu.
  9. Javad Sharifi-Rad: Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador. javad.sharifirad@gmail.com.

Abstract

Cancer is a disease that can cause abnormal cell growth and can spread throughout the body. It is among the most significant causes of death worldwide, resulting in approx. 10 million deaths annually. Many synthetic anticancer drugs are available, but they often come with side effects and can interact negatively with other medications. Additionally, many chemotherapy drugs used for cancer treatment can develop resistance and harm normal cells, leading to dose-limiting side effects. As a result, finding effective cancer treatments and developing new drugs remains a significant challenge. However, plants are a potent source of natural products with the potential for cancer treatment. These biologically active compounds may be the basis for enhanced or less toxic derivatives. Herbal medicines/phytomedicines, or plant-based drugs, are becoming more popular in treating complicated diseases like cancer due to their effectiveness and are a particularly attractive option due to their affordability, availability, and lack of serious side effects. They have broad applicability and therapeutic efficacy, which has spurred scientific research into their potential as anticancer agents. This review focuses on Paclitaxel (PTX), a plant-based drug derived from Taxus sp., and its ability to treat specific tumors. PTX and its derivatives are effective against various cancer cell lines. Researchers can use this detailed information to develop effective and affordable treatments for cancer.

Keywords

References

  1. Oncology (Williston Park). 2000 Jan;14(1):43-52, 57; discussion 58, 61-2 [PMID: 10680149]
  2. Food Sci Nutr. 2023 Apr 17;11(6):2500-2529 [PMID: 37324906]
  3. J Cancer Res Clin Oncol. 2023 Jul;149(7):3871-3883 [PMID: 36006482]
  4. J Ind Microbiol Biotechnol. 2009 Sep;36(9):1171-7 [PMID: 19484278]
  5. Br J Cancer. 2008 May 20;98(10):1608-13 [PMID: 18475293]
  6. Iran J Pharm Res. 2017 Fall;16(4):1432-1442 [PMID: 29552052]
  7. Clio Med. 2002;66:245-67 [PMID: 12028680]
  8. Free Radic Biol Med. 2006 Jul 15;41(2):226-37 [PMID: 16814103]
  9. Biomed Res Int. 2015;2015:413076 [PMID: 26137480]
  10. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2678-81 [PMID: 4941984]
  11. Drug Des Devel Ther. 2014 Feb 20;8:279-84 [PMID: 24591817]
  12. Expert Opin Investig Drugs. 2009 Aug;18(8):1183-9 [PMID: 19604119]
  13. Clin Cancer Res. 2006 Feb 15;12(4):1317-24 [PMID: 16489089]
  14. Science. 1993 Apr 9;260(5105):214-6 [PMID: 8097061]
  15. Molecules. 2023 Apr 23;28(9): [PMID: 37175072]
  16. Microbiology (Reading). 1996 Feb;142 ( Pt 2):435-440 [PMID: 8932715]
  17. PLoS One. 2013 Aug 23;8(8):e73251 [PMID: 24009742]
  18. Molecules. 2023 Feb 15;28(4): [PMID: 36838831]
  19. J Nat Prod. 1994 Jun;57(6):862-7 [PMID: 7931372]
  20. Imprint. 1984 Nov;13(4):58-9 [PMID: 6567594]
  21. Cell Physiol Biochem. 2018;48(4):1433-1442 [PMID: 30064123]
  22. Oncology. 2013;85(4):208-15 [PMID: 24080920]
  23. Fungal Biol. 2015 Nov;119(11):1022-1031 [PMID: 26466877]
  24. Clin Cancer Res. 2002 May;8(5):1038-44 [PMID: 12006516]
  25. Phytochemistry. 2007 Jul;68(14):1844-54 [PMID: 17184797]
  26. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5971-4 [PMID: 18926701]
  27. J Cell Physiol. 2021 Jun;236(6):4121-4137 [PMID: 33230811]
  28. J Nat Prod. 2009 Apr;72(4):626-31 [PMID: 19271717]
  29. Ann Oncol. 2005 Apr;16(4):597-601 [PMID: 15684226]
  30. Mol Biol Cell. 2014 Sep 15;25(18):2677-81 [PMID: 25213191]
  31. Annu Rev Microbiol. 1998;52:361-95 [PMID: 9891802]
  32. J Am Chem Soc. 2008 Dec 10;130(49):16778-85 [PMID: 19554734]
  33. Appl Biochem Biotechnol. 2009 Sep;158(3):675-84 [PMID: 19234679]
  34. World J Microbiol Biotechnol. 2019 May 3;35(5):74 [PMID: 31053977]
  35. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5608-612 [PMID: 6117858]
  36. Biotechnol Appl Biochem. 2009 Jan;52(Pt 1):9-15 [PMID: 18254723]
  37. Nanomedicine (Lond). 2007 Aug;2(4):415-23 [PMID: 17716129]
  38. Free Radic Biol Med. 2010 Apr 15;48(8):1024-33 [PMID: 20083194]
  39. iScience. 2020 Aug 29;23(9):101511 [PMID: 32920486]
  40. Anticancer Drugs. 2020 Mar;31(3):241-250 [PMID: 31633500]
  41. Chemistry. 2016 Aug 1;22(32):11413-21 [PMID: 27376707]
  42. J Control Release. 2001 May 14;72(1-3):191-202 [PMID: 11389998]
  43. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9552-6 [PMID: 8105478]
  44. J Nat Prod. 1990 Sep-Oct;53(5):1249-55 [PMID: 1981374]
  45. Curr Pharm Des. 2001 Sep;7(13):1251-7 [PMID: 11472265]
  46. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1561-5 [PMID: 6103535]
  47. Cancer Chemother Pharmacol. 2010 Jan;65(2):227-34 [PMID: 19479255]
  48. Expert Opin Ther Pat. 2016;26(1):1-20 [PMID: 26651178]
  49. N Engl J Med. 2002 Jan 10;346(2):92-8 [PMID: 11784875]
  50. J Pharmacol Pharmacother. 2013 Oct;4(4):230-7 [PMID: 24250198]
  51. Pneumoftiziologia. 1994 Jul-Dec;43(3-4):173-7 [PMID: 7767101]
  52. Cancer Med. 2019 May;8(5):2325-2337 [PMID: 30957973]
  53. Nat Rev Drug Discov. 2010 Sep;9(9):677-8 [PMID: 20811375]
  54. Chem Rec. 2006;6(6):311-9 [PMID: 17304555]
  55. Curr Pharm Des. 2016;22(33):5127-5143 [PMID: 27215440]
  56. Clin Investig (Lond). 2013;3(4):333-341 [PMID: 26146540]
  57. Cancer Cell Int. 2022 Dec 13;22(1):407 [PMID: 36514100]
  58. Cancer Res. 2006 Apr 1;66(7):3859-68 [PMID: 16585214]
  59. Cancer Cell Int. 2013 Oct 23;13(1):105 [PMID: 24152585]
  60. Invest New Drugs. 1987;5(3):219-29 [PMID: 3667160]
  61. J Appl Microbiol. 2009 Oct;107(4):1202-7 [PMID: 19486395]
  62. Curr Microbiol. 2009 Sep;59(3):227-32 [PMID: 19484305]
  63. Pancreas. 2016 Mar;45(3):425-33 [PMID: 26495780]
  64. Head Neck. 2020 Dec;42(12):3678-3684 [PMID: 32896015]
  65. Bioorg Chem. 2021 Nov;116:105320 [PMID: 34492559]
  66. Phytochemistry. 2002 Jul;60(6):627-31 [PMID: 12126710]
  67. J Clin Oncol. 1999 Jun;17(6):1876-83 [PMID: 10561228]
  68. Oncotarget. 2018 Jan 31;9(36):24304-24319 [PMID: 29849942]
  69. FEMS Microbiol Lett. 2000 Dec 15;193(2):249-53 [PMID: 11111032]
  70. Cell Biosci. 2021 Jul 6;11(1):124 [PMID: 34229754]
  71. Anticancer Agents Med Chem. 2009 Jan;9(1):109-21 [PMID: 19149486]
  72. J Nat Prod. 1990 Nov-Dec;53(6):1609-10 [PMID: 1982448]
  73. Biomed Pharmacother. 2010 Jan;64(1):48-53 [PMID: 19762199]
  74. N Engl J Med. 2008 Apr 17;358(16):1663-71 [PMID: 18420499]
  75. Sci Rep. 2017 Oct 18;7(1):13506 [PMID: 29044153]
  76. Planta Med. 2001 Jun;67(4):374-6 [PMID: 11458463]
  77. Cancer Chemother Pharmacol. 2008 Mar;61(3):453-8 [PMID: 17516069]
  78. Nat Biotechnol. 1996 Sep;14(9):1129-32 [PMID: 9631065]
  79. J Genet Eng Biotechnol. 2015 Dec;13(2):119-127 [PMID: 30647575]
  80. J Biosci. 2008 Jun;33(2):259-67 [PMID: 18535360]
  81. Acta Biochim Biophys Sin (Shanghai). 2015 Dec;47(12):981-7 [PMID: 26525950]
  82. Prikl Biokhim Mikrobiol. 2009 Jan-Feb;45(1):92-6 [PMID: 19235515]
  83. Molecules. 2020 Dec 17;25(24): [PMID: 33348838]
  84. J Nat Prod. 1988 Mar-Apr;51(2):298-306 [PMID: 2898009]
  85. Curr Microbiol. 2017 Jun;74(6):702-709 [PMID: 28332162]
  86. Lancet. 2010 Oct 2;376(9747):1147-54 [PMID: 20888992]
  87. Nat Rev Drug Discov. 2014 Nov;13(11):813-27 [PMID: 25287120]
  88. Curr Opin Investig Drugs. 2006 Dec;7(12):1092-9 [PMID: 17209527]
  89. Mol Cancer Ther. 2010 Nov;9(11):2914-23 [PMID: 20978163]
  90. S Afr Med J. 1986 Mar 29;69(7):413-7 [PMID: 3008355]
  91. Cell Mol Biol Lett. 2019 Jun 13;24:40 [PMID: 31223315]
  92. Cancer Immunol Res. 2020 Aug;8(8):1099-1111 [PMID: 32354736]
  93. J Biosci Bioeng. 2010 Nov;110(5):541-6 [PMID: 20634132]
  94. J Pharm Sci. 2012 Sep;101(9):3292-304 [PMID: 22674061]
  95. Biotechnol Appl Biochem. 2009 Jul 06;54(1):21-30 [PMID: 19067652]
  96. Am J Cancer Res. 2020 Feb 01;10(2):454-472 [PMID: 32195020]
  97. Phytochem Rev. 2006 Feb;5(1):75-97 [PMID: 20622989]
  98. Fungal Biol. 2017 Dec;121(12):1037-1044 [PMID: 29122175]
  99. Front Oncol. 2021 Mar 25;11:629666 [PMID: 33842335]
  100. Eur J Pharm Biopharm. 2005 Jan;59(1):177-87 [PMID: 15567316]
  101. J Am Chem Soc. 1971 May 5;93(9):2325-7 [PMID: 5553076]
  102. Breast Cancer (Auckl). 2012;6:159-71 [PMID: 23133315]
  103. Cancers (Basel). 2023 May 17;15(10): [PMID: 37345131]
  104. J Nat Prod. 2011 Dec 27;74(12):2497-504 [PMID: 22103292]
  105. BMC Microbiol. 2013 Mar 28;13:71 [PMID: 23537181]
  106. Cell Immunol. 2010;263(1):79-87 [PMID: 20346445]
  107. FEMS Microbiol Lett. 2012 Mar;328(2):122-9 [PMID: 22211912]
  108. J Clin Oncol. 1995 Aug;13(8):2039-42 [PMID: 7636546]
  109. PLoS One. 2017 Jun 21;12(6):e0178612 [PMID: 28636663]
  110. J Oncol Pharm Pract. 2006 Dec;12(4):211-22 [PMID: 17156593]
  111. Int J Pharm Sci Res. 2015 Oct 1;6(10):4103-4112 [PMID: 26594645]
  112. Verh Dtsch Ges Inn Med. 1967;73:361-5 [PMID: 5591776]
  113. Acta Chir Belg. 1998 Aug;98(4):176-86 [PMID: 9779243]
  114. Anticancer Res. 2019 Nov;39(11):6155-6163 [PMID: 31704843]
  115. Genes Dis. 2022 Mar 18;10(4):1367-1401 [PMID: 37397557]
  116. Bioorg Med Chem. 2014 Jan 1;22(1):194-203 [PMID: 24332858]
  117. Cancer. 2000 Jun 1;88(11):2619-28 [PMID: 10861441]
  118. Mol Pharm. 2018 Nov 5;15(11):4777-4800 [PMID: 30226786]
  119. Appl Microbiol Biotechnol. 2010 May;86(6):1707-17 [PMID: 20358192]
  120. Mediators Inflamm. 2016;2016:6978936 [PMID: 27293318]
  121. Mol Cancer Ther. 2014 Feb;13(2):275-84 [PMID: 24435445]
  122. J Am Chem Soc. 2009 Apr 29;131(16):5994-6002 [PMID: 19382815]
  123. Invest New Drugs. 2004 Aug;22(3):219-29 [PMID: 15122069]
  124. Nature. 1979 Feb 22;277(5698):665-7 [PMID: 423966]
  125. Mol Cancer Ther. 2013 Aug;12(8):1676-87 [PMID: 23720768]
  126. Apoptosis. 2000 Nov;5(5):415-8 [PMID: 11256882]
  127. Iran J Public Health. 2012;41(11):1-9 [PMID: 23304670]
  128. Clin Dev Immunol. 2011;2011:609579 [PMID: 22110526]
  129. Nucleic Acids Res. 1989 Oct 25;17(20):8389 [PMID: 2813075]
  130. Cancer Res. 2003 Aug 15;63(16):5114-7 [PMID: 12941842]
  131. Drug Des Devel Ther. 2012;6:371-84 [PMID: 23251087]
  132. Angiogenesis. 2013 Jul;16(3):481-92 [PMID: 23389639]
  133. J Microbiol Biotechnol. 2013 Oct 28;23(10):1372-80 [PMID: 23801250]
  134. J Nat Prod. 1999 Aug;62(8):1114-8 [PMID: 10479315]
  135. Oncogene. 2009 Dec 10;28(49):4353-63 [PMID: 19826413]
  136. Braz J Microbiol. 2018 Nov;49 Suppl 1:59-63 [PMID: 30174203]
  137. Sci Transl Med. 2014 Mar 26;6(229):229ra43 [PMID: 24670687]
  138. Appl Microbiol Biotechnol. 2007 Jan;73(6):1233-40 [PMID: 17124581]
  139. Medicine (Baltimore). 2017 Jul;96(27):e7406 [PMID: 28682896]
  140. Sheng Wu Gong Cheng Xue Bao. 2008 Aug;24(8):1433-8 [PMID: 18998547]
  141. Cancer Genomics Proteomics. 2021 Sep-Oct;18(5):661-673 [PMID: 34479918]
  142. Ann Intern Med. 1989 Aug 15;111(4):273-9 [PMID: 2569287]
  143. J Hematol Oncol. 2019 Nov 26;12(1):123 [PMID: 31771633]
  144. Front Pharmacol. 2020 Jan 28;10:1614 [PMID: 32116665]
  145. Int J Pharm. 2005 Mar 23;292(1-2):149-56 [PMID: 15725561]
  146. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Mar 5;138:667-74 [PMID: 25544183]
  147. Nat Rev Cancer. 2004 Apr;4(4):253-65 [PMID: 15057285]
  148. Comput Math Methods Med. 2022 Apr 6;2022:8524951 [PMID: 35432585]
  149. Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1483-1487 [PMID: 28884602]
  150. Appl Microbiol Biotechnol. 2017 Jul;101(14):5831-5846 [PMID: 28612104]
  151. Infect Immun. 1987 Oct;55(10):2327-31 [PMID: 2888730]
  152. Science. 1983 Sep 23;221(4617):1285-8 [PMID: 6137059]
  153. Tumour Biol. 2017 Jun;39(6):1010428317710586 [PMID: 28653898]
  154. Nat Commun. 2017 Nov 9;8(1):1390 [PMID: 29123088]
  155. Biomolecules. 2019 Nov 27;9(12): [PMID: 31783552]
  156. Am J Psychiatry. 1994 Apr;151(4):627 [PMID: 8147479]

MeSH Term

Humans
Paclitaxel
Antineoplastic Agents
Neoplasms
Plants

Chemicals

Paclitaxel
Antineoplastic Agents

Word Cloud

Created with Highcharts 10.0.0cancercandrugsanticancersideeffectseffectivePaclitaxelcellsignificanttreatmentdeveloptreatmentspotentialcompoundsderivativesplant-basedduePTXmechanismsCancerdiseasecauseabnormalgrowthspreadthroughoutbodyamongcausesdeathworldwideresultingapprox10milliondeathsannuallyManysyntheticavailableoftencomeinteractnegativelymedicationsAdditionallymanychemotherapyusedresistanceharmnormalcellsleadingdose-limitingresultfindingdevelopingnewremainschallengeHoweverplantspotentsourcenaturalproductsbiologicallyactivemaybasisenhancedlesstoxicHerbalmedicines/phytomedicinesbecomingpopulartreatingcomplicateddiseaseslikeeffectivenessparticularlyattractiveoptionaffordabilityavailabilitylackseriousbroadapplicabilitytherapeuticefficacyspurredscientificresearchagentsreviewfocusesdrugderivedTaxusspabilitytreatspecifictumorsvariouslinesResearchersusedetailedinformationaffordablesemi-syntheticderivatives:comprehensiveinsightschemicalstructureactionpropertiesAnticancerBioactiveMolecular

Similar Articles

Cited By